Dr. Sara Althari is Managing Director of Biotech & Pharma and Advisor to the Minister at the Saudi Ministry of Investment where she is leading the development and activation of a value chain-based investment strategy for biotechnology in the Kingdom.

In her current capacity, Dr. Althari has launched a series of policy reform initiatives around intellectual property, clinical trials, and data governance to enhance the biotech and innovation ecosystem in KSA. She has also established comprehensive private-public partnerships with leading multinational biopharmaceutical corporations around pillars such as localization of clinical research, biologics manufacturing, talent development, and value-based healthcare solutions.

Prior to this role, Dr. Althari was Research Lead at the Prince Mohammad Bin Salman Foundation (Misk) where she established a policy research arm and designed youth-centric policy solutions with leading knowledge partners and think tanks around youth employment, education, identity and well-being.

Dr. Althari trained in molecular genomics as a research assistant and visiting scholar in institutions such as Harvard Medical School/Brigham and Women’s Hospital and at the Broad Institute of MIT and Harvard.

She holds a PhD in Genetics and Genomics from the University of Oxford where she was a Radcliffe Department of Medicine Scholar. Dr. Althari earned her BA from Wellesley College in Biology and Anthropology where she graduated magna cum laude and Phi Beta Kappa.